Africa: dependable supply of HIV testing reagents needed for crucial early stage TB/HIV testing
This article was originally published in Clinica
Lack of a regular supply of HIV testing reagents is hindering the progress of an integrated TB/HIV testing programme in Malawi. The problem is highlighted in a review of a 2003-2005 HIV testing plan recently published in The International Journal of Public Health 2007 (Bulletin of the World Health Organization). Despite this setback, the initiative's effort to scale up HIV testing for TB and HIV-positive TB patients (one among several objectives) was successful, achieving an increase in HIV tests from 15% in 2003 to 47% in 2005.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.